Anna Morley
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 4
-
- Pleural and Pulmonary Diseases 9
- Occupational and environmental lung diseases 6
- Respiratory Support and Mechanisms 2
- Co-authors
- Nick A. Maskell (16 shared papers)John Harvey (4 shared papers)Clare E. Hooper (4 shared papers)Anthony Edey (4 shared papers)Mike Darby (2 shared papers)Isabel Laurence (1 shared paper)David Arnold (10 shared papers)Andrew R L Medford (4 shared papers)
- Journals
- The Lancet (6 papers)European Respiratory Journal (5 papers)The Lancet Respiratory Medicine (4 papers)The Lancet Regional Health - Europe (4 papers)Lung Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesNepal
In The Last Decade
Anna Morley
40 papers receiving 4k citations
Anna Morley's Hit Papers
Peers
Comparison fields: 5 of 107
- Internal Medicine 721
- Infectious Diseases 1.6k
- Neurology 441
- Pulmonary and Respiratory Medicine 737
- Applied Microbiology and Biotechnology 37
Countries citing papers authored by Anna Morley
This map shows the geographic impact of Anna Morley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Morley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Morley more than expected).
Fields of papers citing papers by Anna Morley
This network shows the impact of papers produced by Anna Morley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Morley. The network helps show where Anna Morley may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Morley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions Hit paper breakdown → | 2013 | 1002 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Hit paper breakdown → | 2022 | 310 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 252 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | 2021 | 213 | |
| 9 | 2018 | 145 | |
| 10 | 2022 | 123 | |
| 11 | 2022 | 87 | |
| 12 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 13 | 2015 | 66 | |
| 14 | Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Hit paper breakdown → | 2024 | 65 |
| 15 | 2020 | 50 | |
| 16 | 2021 | 50 | |
| 17 | 2015 | 48 | |
| 18 | 2023 | 35 | |
| 19 | 2008 | 24 | |
| 20 | 2024 | 24 |
About Anna Morley
Anna Morley is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Neurology, Epidemiology and Geriatrics and Gerontology, having authored 42 papers that have together received 4.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Pleural and Pulmonary Diseases (9 papers), Long-Term Effects of COVID-19 (8 papers), Occupational and environmental lung diseases (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Pneumonia and Respiratory Infections (2 papers), Respiratory Support and Mechanisms (2 papers) and Sleep and related disorders (1 paper). The work is most often cited by research in Internal Medicine (721 citations), Infectious Diseases (1.6k citations), Neurology (441 citations), Pulmonary and Respiratory Medicine (737 citations) and Applied Microbiology and Biotechnology (37 citations). Anna Morley has collaborated with scholars based in United Kingdom, United States and Nepal. Frequent co-authors include Nick A. Maskell, John Harvey, Clare E. Hooper, Anthony Edey, Mike Darby, Isabel Laurence, David Arnold, Andrew R L Medford, Duneesha de Fonseka and Paul White. Their work appears in journals such as The Lancet, European Respiratory Journal, The Lancet Respiratory Medicine, The Lancet Regional Health - Europe and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.